Squamous cell carcinoma of the prostate: a transformation from adenocarcinoma after the use of a luteinizing hormone-releasing hormone agonist and flutamide.
作者信息
Braslis K G, Davi R C, Nelson E, Civantos F, Soloway M S
机构信息
Department of Urology and Pathology, University of Miami School of Medicine, Florida.
出版信息
Urology. 1995 Feb;45(2):329-31. doi: 10.1016/0090-4295(95)80028-x.
PMID:7855985
Abstract
We report a primary squamous cell carcinoma of the prostate that developed in a 57-year-old man, 3 years after treatment with leuprolide and flutamide for Stage D1 adenocarcinoma of the prostate. This is the first case that describes this transformation from adenocarcinoma to squamous cell carcinoma following the use of luteinizing hormone agonists.
摘要
Zotero 插件